keynote-355: pembrolizumab in triple-negative breast cancer
Published 1 year ago • 18 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
2:07
keynote-355: pembrolizumab in triple-negative breast cancer
-
12:45
keynote-355: first-line pembrolizumab plus chemotherapy for metastatic triple-negative breast ca...
-
1:30
keynote-355: hrqol unaffected by the addition of pembrolizumab to chemotherapy for tnbc
-
4:49
keynote-355: pembro chemo in triple-negative breast cancer
-
2:00
pembrolizumab plus chemotherapy show efficacy for tnbc in keynote-355
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
3:18
#esmo21 highlights on combination of pembrolizumab plus chemotherapy in mtnbc: the keynote-355 study
-
2:34
esmo 2021 breast cancer highlights: tulip and keynote-355
-
4:11
asco 2020: pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast c...
-
4:53
chemoimmunotherapy in tnbc: the keynote-355 trial
-
1:35
longer overall survival in metastatic tnbc with pembrolizumab - medpage today
-
1:42
the case for neoadjuvant pembrolizumab in tnbc
-
4:54
hope rugo, md, shares the design and outcomes of keynote-355 presented at sabcs 2020
-
5:37
researcher comment: the keynote-355 trial | javier cortes
-
4:54
keynote-522 updates: pembrolizumab plus neoadjuvant chemotherapy in early triple-negative breast...
-
3:09
keynote-522: neoadjuvant and adjuvant pembrolizumab for early tnbc
-
4:20
keynote 522: pembrolizumab as neoadjuvant treatment for early tnbc
-
6:16
latest on immunotherapy in triple-negative breast cancer - medpage today